申请人:Arrington L. Kenneth
公开号:US20070060601A1
公开(公告)日:2007-03-15
The present invention relates to 2,3-diarylquinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
本发明涉及对细胞增殖性疾病有用的2,3-二芳基喹唑啉酮化合物,用于治疗与KSP动力蛋白活性相关的疾病,并抑制KSP动力蛋白。该发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。